Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene's Commercial Presence in APAC 2025-03-05 13:00
Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept 2025-03-03 22:00
Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics 2025-03-03 21:00
Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma 2025-03-03 08:00
A*STAR And MojiaBio To Develop Next-gen Sustainable Biomanufacturing Platform In Singapore 2025-02-28 18:00
Everest Medicines to Hold Investor Calls with Updates on mRNA Therapeutic Vaccine Programs 2025-02-28 14:28
KBP to Contest Injunction Obtained by Novo Nordisk 2025-02-28 09:00
EpiVax Strengthens Technology Leadership Amid Immunoinformatics Advancements 2025-02-27 22:05
Metabolon Unveils New Multiomics Biomarker Discovery Functionality via its Industry-leading Integrated Bioinformatics Platform 2025-02-27 22:00
WuXi Biologics Again Passed GMP Inspection by Japan PMDA 2025-02-27 16:30
First Patient Dosed in a Phase III Clinical Study of Anti-HER2 Biparatopic ADC JSKN003 for the Treatment of HER2-positive Breast Cancer 2025-02-27 14:06
The debate on MSCs is over; it's time to promote MSC therapy in practice 2025-02-27 12:57
ECR 2025: Esaote Group presents Integrated Medical Imaging Solutions and unveils innovations in Ultrasound Technology 2025-02-26 21:00
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review 2025-02-26 08:49
Everest Medicines Presents Complete Maintenance Period Data for Etrasimod at ECCO 2025 2025-02-26 07:45
LabConnect and Australian Clinical Labs' Specialised Trials Announce Strategic Partnership in Australia and Asia Pacific Region 2025-02-24 22:06
Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI 2025-02-24 21:00
NMPA Accepts NDA and Grants Priority Review Designation to Innovent's Ipilimumab Injection, China's First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon Cancer 2025-02-24 07:56
Ascletis Announces Positive Interim Results from First Two Cohorts of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 2025-02-19 20:00
Hong Kong to Host Landmark International Symposium on Genomic Medicine 2025-02-19 11:43
1 26 27 28 29 30 264